ROLE OF PAPILLOMAVIRUS IN CERVICAL NEOPLASIA
乳头状病毒在宫颈肿瘤中的作用
基本信息
- 批准号:3170537
- 负责人:
- 金额:$ 18.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-01-01 至 1992-05-31
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli Papillomavirus biopsy cervix neoplasms gene expression genetic manipulation genetic mapping genetic recombination human tissue immunofluorescence technique in situ hybridization laboratory mouse laboratory rabbit microorganism immunology molecular cloning monoclonal antibody neoplasm /cancer immunology nucleic acid hybridization nucleic acid sequence oncogenic virus spectrometry tumor antigens virus DNA virus antigen virus genetics
项目摘要
Recent molecular virologic and immunologic studies have shown a
relationship between human papillomavairus (HPV) infection and dysplasia of
the uterine cervix. The significance of these observations is underscored
by the fact that dysplasias are considered precursor lesions to cervical
carcinoma. The specific aims of this proposal are to characterize HPV
sequences from dysplasias by molecular cloning for the purpose of
identifying the various HPV types associated with these lesions using
molecular hybridization and immunological tests with antibodies directed
against virus type-specific poly- or oligopeptides.
HPV sequences will be cloned into plasmid or Charon vectors and
subsequently characterized by hybridization to DNAs of known HPV types.
These cloned DNAs will be used in blot transfer and in situ hybridization
experiments with dysplasias and cervical carcinomas. Sequence analysis of
the viral DNAs will provide necessary information for the synthesis of
virus type-specific structural polypeptides in bacterial expression vector
systems or synthesis of oligopeptides by solid-phase chemistry. The
resultant antibodies will be used to screen biopsy specimens to determine
the HPV type associated with dysplasias which regress and those which
progress to more serious disease. Antibodies directed against
papillomavirus genus-specific nonstructural (transforming) proteins will be
synthesized in bacteria for use in immunocytochemical studies on cervical
cancers.
From the behavior of cervical dysplasia (regression or progression) it
would be of prognostic and/or diagnostic value to be able to predict the
outcome of HPV infection of the cervix. Such information could provide a
more rational approach to the management of cervical neoplasia.
最近的分子病毒学和免疫学研究表明
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE D LANCASTER其他文献
WAYNE D LANCASTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE D LANCASTER', 18)}}的其他基金
Cervical Cancer Cofactors and HPV DNA Integration
宫颈癌辅助因子和 HPV DNA 整合
- 批准号:
6942673 - 财政年份:2004
- 资助金额:
$ 18.92万 - 项目类别:
Cervical Cancer Cofactors and HPV DNA Integration
宫颈癌辅助因子和 HPV DNA 整合
- 批准号:
6821609 - 财政年份:2004
- 资助金额:
$ 18.92万 - 项目类别:
HPV INTEGRATION AS A BIOMARKER FOR CIN BEHAVIOR
HPV 整合作为 CIN 行为的生物标志物
- 批准号:
6607280 - 财政年份:2002
- 资助金额:
$ 18.92万 - 项目类别:
HPV INTEGRATION AS A BIOMARKER FOR CIN BEHAVIOR
HPV 整合作为 CIN 行为的生物标志物
- 批准号:
6548232 - 财政年份:2002
- 资助金额:
$ 18.92万 - 项目类别:
PAPILLOMAVIRUS DNA AND ANTIGENS IN CERVICAL NEOPLASIA
宫颈肿瘤中的乳头瘤病毒 DNA 和抗原
- 批准号:
3170533 - 财政年份:1984
- 资助金额:
$ 18.92万 - 项目类别:
PAPILLOMAVIRUS DNA AND ANTIGENS IN CERVICAL NEOPLASIA
宫颈肿瘤中的乳头瘤病毒 DNA 和抗原
- 批准号:
3170534 - 财政年份:1984
- 资助金额:
$ 18.92万 - 项目类别:
相似海外基金
Understanding oncogenic human papillomavirus persistence and immune modulation in tonsil epithelia
了解致癌人乳头瘤病毒在扁桃体上皮中的持久性和免疫调节
- 批准号:
MR/Y001753/1 - 财政年份:2024
- 资助金额:
$ 18.92万 - 项目类别:
Research Grant
Validating the Use of Point-Of-Care Diagnostics for Early Detection of Human Papillomavirus
验证床旁诊断在人乳头瘤病毒早期检测中的应用
- 批准号:
EP/Y003225/1 - 财政年份:2024
- 资助金额:
$ 18.92万 - 项目类别:
Research Grant
Carcinogenic risk assessment by human papillomavirus infection using next-generation sequencing
使用下一代测序评估人乳头瘤病毒感染的致癌风险
- 批准号:
23KJ1536 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
A co-infection model for papillomavirus associated infections and cancers
乳头瘤病毒相关感染和癌症的共感染模型
- 批准号:
10667710 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Rapid Point of Care Test to Screen Human Papillomavirus in Low-Resource Settings
在资源匮乏的环境中筛查人乳头瘤病毒的快速护理点测试
- 批准号:
10897682 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Interactions between human papillomavirus infections, bacterial vaginosis, and genital microbiomes of sex partners
人乳头瘤病毒感染、细菌性阴道病和性伴侣生殖器微生物组之间的相互作用
- 批准号:
488743 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Operating Grants
Non-vaccine High-risk Human Papillomavirus genital infection, a neglected threat in underscreened immigrant and refugee women from Sub-Saharan Africa living in Canada.
非疫苗高危人乳头瘤病毒生殖器感染,是生活在加拿大的来自撒哈拉以南非洲的未筛查移民和难民妇女的一个被忽视的威胁。
- 批准号:
491106 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Fellowship Programs
SBIR PA22-176 - Rapid Point-of-Care Detection of Human Papillomavirus
SBIR PA22-176 - 人乳头瘤病毒的快速护理点检测
- 批准号:
10761537 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Regulation of the Human Papillomavirus Life Cycle by the Long Noncoding RNA DINO
长非编码 RNA DINO 对人乳头瘤病毒生命周期的调节
- 批准号:
10743142 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
项目 1 - 人乳头瘤病毒感染和肿瘤发生的分子遗传学
- 批准号:
10910335 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:














{{item.name}}会员




